复方丹参滴丸联合复方倍他米松治疗口腔黏膜下纤维性变1例

doi:10.12337/zgkqjxjyzz.2025.06.007

中国口腔医学继续教育杂志 ›› 2025, Vol. 28 ›› Issue (6): 422-427.DOI: 10.12337/zgkqjxjyzz.2025.06.007

复方丹参滴丸联合复方倍他米松治疗口腔黏膜下纤维性变1例

田亚敏^1,2,*, 李宜宸^1,2, 丁伟^1,2

¹内蒙古医科大学附属医院口腔科;
²内蒙古医科大学口腔医学院

出版日期:2025-11-30 发布日期:2025-11-30
通讯作者: ^*田亚敏,联系方式：0471-3451216,电子邮箱：905392620@qq.com,通讯地址：内蒙古自治区呼和浩特市回民区通道北街1号,010030

Compound Danshen Dropping Pills Combined with Compound Betamethasone in Treatment of Oral Submucous Fibrosis: A Case Report

Yamin Tian^1,2,*, Yichen Li^1,2, Wei Ding^1,2

¹Department of Stomatology, the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, Inner Mongolia , P.R. China;
²School & Hospital of Stomatology, Inner Mongolia Medical University, Hohhot, Inner Mongolia, P.R. China

Online:2025-11-30 Published:2025-11-30
Contact: Yamin Tian. Tel: 0471-3451216. Email: 905392620@qq.com. Address: No.5 Xinhua Street, Huimin District, Hohhot 010030, Inner Mongolia, P.R. China.

摘要/Abstract

摘要： 目的：本病例报道口腔黏膜下纤维性变（oral submucous fibrosis,OSF）1例使用复方丹参滴丸联合复方倍他米松的治疗过程,旨在为OSF治疗提供临床经验。诊治经过：在明确诊断及患者知情同意后,对患者行口腔黏膜病损局部封闭复方倍他米松治疗,同时配合口服复方丹参滴丸治疗。结果：治疗8周后,取得了良好的临床效果。结论：复方丹参滴丸联合复方倍他米松注射液治疗OSF起到抗炎,改善局部微血管循环的协同作用,使症状快速有效地改善。

关键词: 口腔黏膜下纤维性变, 复方丹参滴丸, 复方倍他米松, 中西医结合, 局部封闭

Abstract: Objective: This case report presents the treatment process of a case of oral submucous fibrosis (OSF) using Compound Danshen Dripping Pills combined with Compound Betamethasone, aiming to provide clinical experience for the treatment of OSF. Diagnosis and treatment: After a clear diagnosis and informed consent from the patient, the patient underwent local blocking therapy with Compound Betamethasone for oral mucosal lesions, accompanied by oral administration of Compound Danshen Dripping Pills. Results: After 8 weeks of treatment, good clinical effects were achieved. Conclusions: The combination of Compound Danshen Pills and Compound Betamethasone Injection can exert a synergistic effect, which not only exerts an anti-inflammatory effect but also improves local microvascular microcirculation, leading to more effective symptom relief.

Key words: oral submucous fibrosis, Compound Danshen Dripping Pills, Compound Betamethasone, integrated traditional Chinese and Western medicine, localized blocking therapy

田亚敏, 李宜宸, 丁伟. 复方丹参滴丸联合复方倍他米松治疗口腔黏膜下纤维性变1例[J]. 中国口腔医学继续教育杂志, 2025, 28(6): 422-427.

Yamin Tian, Yichen Li, Wei Ding. Compound Danshen Dropping Pills Combined with Compound Betamethasone in Treatment of Oral Submucous Fibrosis: A Case Report[J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(6): 422-427.

参考文献

[1] Society of Oral Medicine; Chinese Stomatological Association. Guideline for the Diagnosis and Clinical Management of Oral Submucous Fibrosis[J]. Chin J Dent Res, 2023, 26(4):271-285.
[2] Wang L, Tang Z.Immunopathogenesis of oral submucous fibrosis by chewing the areca nut[J]. J Leukoc Biol, 2022, 111(2):469-476.
[3] Yoithapprabhunath TR, Maheswaran T, Dineshshankar J, et al.Pathogenesis and therapeutic intervention of oral submucous fibrosis[J]. J Pharm Bioallied Sci, 2013, 5(Suppl 1):S85-S88.
[4] Tang J, Liu J, Zhou Z, et al.Oral submucous fibrosis: pathogenesis and therapeutic approaches[J]. Int J Oral Sci, 2025, 17(1):8.
[5] Singh P, Rai A, Dohare R, et al.Network-based identification of signature genes KLF6 and SPOCK1 associated with oral submucous fibrosis[J]. Molec Clin Oncol, 2020, 12(4):299-310.
[6] 王雨田,黄国栋,刘子建,等. 口腔黏膜下纤维性变癌变的研究进展[J]. 中国口腔医学继续教育杂志, 2022, 25(3):129-135.
[7] Gupta N, Kalaskar A, Kalaskar R.Efficacy of lycopene in management of Oral Submucous Fibrosis-A systematic review and meta-analysis[J]. J Oral Biol Craniofac Res, 2020, 10(4):690-697.
[8] Singh AG, Roy S, Oza S, et al.A contemporary narrative review to guide molecular epidemiology of oral submucous fibrosis[J]. Int J Mol Epidemiol Genet, 2021, 12(4):61-70.
[9] Zhang P, Chua NQE, Dang S, et al.Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents-Does Fibroblast Senescence Play a Role?[J]. Int J Mol Sci, 2022, 23(3):1637.
[10] Wang J, Yang L, You J, et al.Platelet-derived growth factor regulates the biological behavior of oral mucosal fibroblasts by inducing cell autophagy and its mechanism[J]. J Inflam Res, 2021, 14:3405-3417.
[11] 陈冠君,符骁,冼海瑜,等. 133例口腔黏膜下纤维性变癌变的病理及临床生物学行为研究[J]. 国际口腔医学杂志, 2024, 51(5):532-537.
[12] 唐瞻贵,成雨熹. 口腔黏膜下纤维性变临床诊治的研究进展[J]. 口腔医学研究, 2022, 38(8):705-709.
[13] 郭锦材,谢辉. 口腔黏膜下纤维性变治疗的循证医学研究[J]. 口腔疾病防治, 2024, 32(12):907-915.
[14] 宋韬,何洪立. 曲安奈德联合康复新液治疗老年口腔黏膜下纤维性变疗效及患者炎症因子水平变化[J]. 中国老年学杂志, 2022, 42(14):3487-3489.
[15] Liu C,Xie B,Yang Y,et al.Efficacy of intralesional betamethasone for erosive oral lichen planus and evaluation of recurrence: a randomized controlled trial[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 116(5):584-590.
[16] 王雅娇,沈梦圆,王琰,等.富血小板血浆凝胶联合复方倍他米松治疗糜烂型口腔扁平苔藓效果研究[J].中国实用口腔科杂志, 2024, 17(3):299-305.
[17] 刘爱丽,闫振峰,毛远兴.泼尼松龙治疗口腔黏膜下纤维性变的临床效果观察[J].北京口腔医学, 2021, 29(2):93-96.
[18] 李璐瑶,刘水冰,冯斌,等.复方丹参滴丸在口腔黏膜疾病治疗中的超说明书使用情况分析[J].中国药物应用与监测, 2025, 22(3):495-498.
[19] 罗雪晴,周文伟. 复方丹参滴丸治疗口腔扁平苔藓临床观察[J]. 实用中医药杂志, 2021, 37(11):1943-1944.
[20] 李涛. 曲安奈德联合丹参酮注射液治疗口腔黏膜下纤维化的临床效果[J].临床医学研究与实践, 2022, 7(15):42-45.
[21] Cai X, Zhang H, Li T.Multi-target pharmacological mechanisms of Salvia miltiorrhiza against oral submucous fibrosis: A network pharmacology approach[J]. Arch Oral Biol, 2021, 126:105131.
[22] 郭锦材, 谢辉. 天然药物提取物治疗口腔黏膜下纤维性变的临床研究进展[J]. 临床口腔医学杂志, 2018, 34(11):692-695.
[23] Daga D, Singh RK, Pal US, et al.Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis[J]. Natl J Maxillofac Surg, 2017, 8(1):50-54.
[24] 蔡鑫嘉, 黄俊辉, 姚志刚, 等. 丹参联合曲安奈德局部注射治疗口腔黏膜下纤维性变的meta分析[J]. 口腔疾病防治, 2018, 26(6):374-378.
[25] 王凤凤,王涛,李传真.口腔黏膜下纤维性变的临床治疗研究进展[J].中华全科医学, 2022, 20(7):1203-1206.
[26] Xu H, Lyu FY, Song JY, et al.Research Achievements of Oral Submucous Fibrosis: Progress and Prospect[J]. Biomed Res Int, 2021, 2021:6631856.

复方丹参滴丸联合复方倍他米松治疗口腔黏膜下纤维性变1例

Compound Danshen Dropping Pills Combined with Compound Betamethasone in Treatment of Oral Submucous Fibrosis: A Case Report

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	崔鸢, 刘杨, 宋萌萌, 王新文, 刘青. 三叉神经带状疱疹伴拉姆齐-亨特综合征1例[J]. 中国口腔医学继续教育杂志, 2025, 28(6): 438-443.
[2]	王雨田, 黄国栋, 刘子建, 刘宏伟. 口腔黏膜下纤维性变癌变的研究进展[J]. 中国口腔医学继续教育杂志, 2022, 25(3): 129-135.